Evidence map›Paper›PMID 42587137›Full record

ArticleNature biotechnology2026

Discovery and design of potent cell surface display elements.

Zhenhao Fang, Joshua Saskin, Seok-Hoon Lee, Charles Zou, Shan Xin, Xiaoyu Huang, Xingxin Pan, Chuanpeng Dong, Ardavan Abiri, Yanzhi Feng and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zhenhao Fang *Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-1246-3665
Joshua Saskin *Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5372-9696
Seok-Hoon LeeDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Charles ZouDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Shan XinDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Xiaoyu HuangDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Xingxin PanDepartment of Neurosurgery, Baylor College of Medicine, Temple, TX, USA.ORCID http://orcid.org/0000-0002-4429-4878
Chuanpeng DongDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Ardavan AbiriDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Yanzhi FengDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Nidhi SahniDepartment of Neurosurgery, Baylor College of Medicine, Temple, TX, USA.
S Stephen YiDepartment of Neurosurgery, Baylor College of Medicine, Temple, TX, USA.
Lei PengDepartment of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-7159-5441
Sidi ChenDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA. chensidi@gmail.com.ORCID http://orcid.org/0000-0002-3819-5005

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell surface display (CSD) elements are a major class of bioengineering modules, but systematic rules linking CSD sequence to functional potency are lacking. Here we develop DeepSCan, a suite of deep learning and artificial intelligence models to systematically map CSD sequence-function relationships to reliably capture potent elements' conserved features and iteratively design and develop potent de novo CSD modules for mRNA antigen display. We experimentally quantify surface expression across >570 chimeric antigens, derive cell surface translocation strength labels for ~310 CSD elements and compile ~45 independent training datasets. We train three generations of DeepSCan models and evaluate their performance. Guided by these models, we computationally design 3,700 and experimentally validate approximately 120 generative CSDs, identifying 7 generative CSDs that match or exceed the cell surface translocation strength of the most potent naturally occurring CSDs. Enhanced surface displays are validated across multiple cell types and are functional in an antigen-specific CAR-T cytotoxicity assay.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.